|
| (2Z,5Z)-5-(4-hydroxy-3,5-dimethoxybenzylidene)-3-phenyl-2-(phenylimino)-1,3-thiazolidin-4-one |
|
Salmonella
Yersinia |
TTSS (SPI-1 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Felise HB, et al. 2008. Cell Host Microbe
|
|
| Mitoxantrone hydrochloride |
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
| Sepantronium bromide |
|
Escherichia
Salmonella |
TTSS secreted effectors
TTSS-2 secreted effectors |
Phase II trial
Preclinical (in vitro) |
El Qaidi S, et al. 2018. Front Cell Infect Microbiol; Zhu C, et al. 2021. Pathogens
|
|
| Propofol |
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
| Mefenamic acid |
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
| 3,4-DIMETHYLBENZOIC ACID |
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
Peixoto RJM, et al. 2017. Appl Environ Microbiol |
|
| 4-chloro-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide |
|
Chlamydia
Salmonella
Shigella |
TTSS (Type III secretion system)
TTSS (SPI-1 encode); TTSS (SPI-2 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro) |
Muschiol S, et al. 2006. Proc Natl Acad Sci U S A
Negrea A, et al. 2007. Antimicrob Agents Chemother
Veenendaal AK, et al. 2009. J Bacteriol |
|
| (E)-N'-(2,3,4-Trihydroxybenzylidene)benzohydrazide |
|
Escherichia
Salmonella |
TTSS (Type III secretion system)
TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro)
Preclinical (in vitro) |
Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem
Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
| N-[(E)-(2,3,4-trihydroxyphenyl)methylideneamino]furan-2-carboxamide |
|
Salmonella
Shigella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother
Veenendaal AK, et al. 2009. J Bacteriol |
|
| N'-(3,5-Dibromosalicylidene)-4-nitrobenzhydrazide |
|
Salmonella
Yersinia |
TTSS (SPI-1 encode); TTSS (SPI-2 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother
Kauppi AM, et al. 2003. Chem Biol; Nordfelth R, et al. 2005. Infect Immun |
|
| | | |
